Departamentos

Pedro Antonio Reche Gallardo

Full Professor of Immunology

Contact

 

Departamento de

Immunologia,

Facultad de Medicina 

Universidad Complutense de Madrid

28040, Madrid, España

EM: parecheg at med . ucm . es

 
 aca

Education

  • 1995 – PhD in Chemistry, Bioquemistry. University of Granada, Granada, Spain

  • 1990 – Bachelor Degree in Chemistry. Faculty of Sciences, University of Granada, Spain.


Research Career

  • 06/2006–present. Immunomedicine Group Leader. Department of Immunology, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain

    • Topic: Immunomedicine and Immunonformatics.

  • 07/2005–06/2006. Director of the Department of Bioinformatics of the Cancer Vaccine Center. Dana-Farber Institute, Harvard Medical School, Boston, MA, USA

    • Topic: Computational Immunology and Cancer Immunothrerapy.

    • Reporting to: Prof. Ellis L. Reinherz, Director

  • 03/2001–06/2006. Research Scientist. Dana-Farber Institute, Harvard Medical School, Boston, MA, USA

    • Topic: Molecular basis of Immune Recognition.

    • Reporting to: Prof. Ellis L. Reinherz, Chief of the laboratory of Immunobiology

  • 05/1998–02/2001. Postodoctoral Scientist at DNAX, Research Institute, Palo Alto, CA, USA.

    • Topic: Discovery and functional analysis of novel molecules.

    • Funding: Post-Doctoral Fellowship from DNAX Research Institute

    • Supervisor: Dr. Fernando J. Bazan

  • 09/1995–06/1998. Post-doctoral Scientist at Dept. of Biochemistry, University of Cambridge, UK.

    • Topic: Molecular and structural bases of the post-translational modification of biotinyl and lipoyl domains. Protein-protein interactions underlying catalysis and protein assemble in multienzyme complexes.

    • Funding: FEBS Fellowship (09/1995 – 08/1997) and BBSRC Research Associate contract (09/1997–05/1998)

    • Supervisor: Prof. Richard N. Perham

  • 09/90-06/95 PhD Student at Instituto de Parasitología y Biomedicina" (CSIC), Granada, Spain.

    • Topic: Identification and characterization of potential drug targets in Trypanosoma cruzi

    • Funding: PhD Fellowship from Junta de Andalucia, Spain

    • Supervisor: Dr. Luis Miguel Ruiz Perez & Dra. Dolores Gonzalez Pacanowska